Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine
Rita de Cássia Collaço(Ghent University), Frank Bosmans(Vrije Universiteit Brussel), David Valle(Government of the United States of America), Edward Liu(Johns Hopkins University), Carley Blevins(Johns Hopkins University), Maxime Lammens(Ghent University), Peter C. Rowe(Johns Hopkins University), Suguru Yamauchi(Johns Hopkins University), Elizabeth Wohler(Johns Hopkins University), Jinny S. Ha(Sidney Kimmel Comprehensive Cancer Center), Malcolm V. Brock(Johns Hopkins University), Yuping Mei(Johns Hopkins Hospital), Christine Kim, Corrine Boehm(Johns Hopkins University), Jeannine Forrester(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Nara Sobreira(Johns Hopkins University), Andrei Gurau(Johns Hopkins University)
Cited by 9
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|909
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer
|Cancer Discovery|2011|681
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
|Cancer Cell|2012|652
Implementing genomic medicine in the clinic: the future is here
|Genetics in Medicine|2013|581